American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

CERO THERAPEUTICS HOLDINGS, INC. (CERO)

$0.01 -11.50% OTC: CERO · 15-min delayed

SOUTH SAN FRANCISCO, California
Public · OTC: CERO

-$19.9MNet income

CEROOTC

About CERO THERAPEUTICS HOLDINGS, INC.

CERO TERAPEUTICS HLDG INC

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Company facts

Type: Public · OTC: CERO
Headquarters: SOUTH SAN FRANCISCO, California
Industry: Pharmaceuticals

Registry IDs

Ticker: CERO OTC
SEC CIK: 1870404
EIN: 871088814
SIC: 2836 Biological Products, (No Diagnostic Substances)

Embed this company’s badge

Show Cero Therapeutics Holdings, Inc.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/cero-therapeutics-holdings-inc/"><img src="https://americancompanies.com/badge/cero-therapeutics-holdings-inc.svg" alt="Cero Therapeutics Holdings, Inc. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it, control the page, and earn the Verified badge.

Claim this profile

Track American companies

Create a free account to follow CERO THERAPEUTICS HOLDINGS, INC. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Net income: -$19.9M
Total assets: $3.6M

Source: SEC EDGAR · updated Jun 8, 2026

FY 2024

Financial statements

Income statement

Revenue: $0
Operating expenses: $16.2M
Operating income: -$16.2M
Net income: -$8.3M
EPS (basic): $-116.05
EPS (diluted): $-116.05

Balance sheet

Total assets: $6.2M
Current assets: $3.7M
Total liabilities: $8.1M
Current liabilities: $7.4M
Shareholders’ equity: -$1.9M

Statements via Polygon.io (SEC filings)

OTC: CERO

$0.01 -11.50%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.01 $11.19

52-week range

EPS (diluted): $-116.05000000000001
Open: —
Day range: –
Prev close: —
Volume: —

Cero Therapeutics Holdings, Inc. (CERO) Stock Price

Reported a net loss of $19.9M.
Trading 100% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review CERO THERAPEUTICS HOLDINGS, INC..

Write a review

Newsroom

News about CERO THERAPEUTICS HOLDINGS, INC.

CERo Therapeutics Announces Receipt of Nasdaq Panel Determination GlobeNewswire Inc. · 2025-10-29 · negative CERo Therapeutics, Inc. Appoints Chris Ehrlich CEO GlobeNewswire Inc. · 2024-12-06 · positive CERo Therapeutics, Inc. Completes IND-Enabling Activities Following Successful Manufacturing Runs for Lead Compound CER-1236 GlobeNewswire Inc. · 2024-06-13 CERo Therapeutics, Inc. Provides Corporate Update for Shareholders GlobeNewswire Inc. · 2024-05-15 Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Benzinga · 2024-03-28 Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket Benzinga · 2024-03-20

News & sentiment via Polygon.io

FAQ

Cero Therapeutics Holdings, Inc.: frequently asked questions

Is Cero Therapeutics Holdings, Inc. an American company?

Cero Therapeutics Holdings, Inc. is a US-based company headquartered in South San Francisco, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Cero Therapeutics Holdings, Inc. headquartered?

Cero Therapeutics Holdings, Inc. is headquartered in South San Francisco, California, United States.

Is Cero Therapeutics Holdings, Inc. publicly traded?

Yes — Cero Therapeutics Holdings, Inc. is a publicly traded company. Its stock trades under the ticker symbol CERO on the OTC.

What does Cero Therapeutics Holdings, Inc. do?

Cero Therapeutics Holdings, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore